Contribution of Cytogenetics to the Management of Poorly Differentiated Sarcomas

References

• Tijo JH, Levan A. The chromosome number of man. Hereditas 1956; 42: 1–6
   Google Scholar
• Hsu TC. Mammalian chromosomes in vitro: the chromosomes of man. J Hered 1952; 43: 167–172
   Web of Science ®Google Scholar
• Seabright M. A rapid banding technique for human chromosomes. Lancet 1971; 2: 971–972
   PubMed Web of Science ®Google Scholar
• Turc-Carel C, Philip I, Berger MP, Philip T, Lenoir GM. Translocation t(11;22)(q24;q12) in Ewing sarcoma cell lines. N Engl J Med 1983; 309: 497–498
   Web of Science ®Google Scholar
• Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA. Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 1984; 311: 584–585
   PubMed Web of Science ®Google Scholar
• Sandberg, AA, Bridge, JA. The Cytogenetics of Bone and Soft Tissue Tumors. RG Landes, CRC Press, Austin, TX 1994
   Google Scholar
• Mitelman F, Johansson B, Mertens F, eds. Mitelman database of chromosome aberrations in cancer; 2006. http://cgap.nci.nih.gov/Chromosomes/Mitelman.
   Google Scholar
• Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol 2000; 31: 532–538
   PubMedGoogle Scholar
• Xia SJ, Barr FG. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. Eur J Cancer 2005; 41: 2513–2527
   PubMed Web of Science ®Google Scholar
• Antonescu CR. The role of genetic testing in soft tissue sarcoma. Histopathology 2006; 48: 13–21
   PubMed Web of Science ®Google Scholar
• Gisselsson D, Palsson E, Hoglund M, et al. Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma. Genes Chromosomes Cancer 2002; 33: 133–140
   PubMed Web of Science ®Google Scholar
• Dei Tos AP, Doglioni C, Piccinin S, et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 2000; 190: 531–536
   PubMed Web of Science ®Google Scholar
• Polito P, Dal Cin P, Sciot R, Brock P, Van Eyken P, Van den Berghe H. Embryonal rhabdomyosarcoma with only numerical chromosome changes: case report and review of the literature. Cancer Genet Cytogenet 1999; 109: 161–165
   PubMedGoogle Scholar
• Weber-Hall S, Anderson J, McManus A, et al. Gains, losses and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 1996; 56: 3220–3224
   PubMed Web of Science ®Google Scholar
• Koga T, Iwasaki H, Ishiguro M, Matsuzaki A, Kikuchi M. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis. J Pathol 2002; 197: 98–107
   PubMedGoogle Scholar
• Bridge RS, Jr., Bridge JA, Neff JR, Naumann S, Althof P, Bruch LA. Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. J Clin Pathol 2004; 57: 1172–1178
   PubMedGoogle Scholar
• Bridge JA, Nelson M, McComb E, et al. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet 1997; 95: 74–87
   Google Scholar
• Gorlick R, Anderson P, Andrulis I, et al. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res 2003; 9: 5442–5453
   PubMed Web of Science ®Google Scholar
• Mertens F, Fletcher CD, Dal Cin P, et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Genes Chromosomes Cancer 1998; 22: 16–25
   PubMed Web of Science ®Google Scholar
• Mandahl N, Fletcher CD, Dal Cin P, et al. Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues: a report from the CHAMP Study Group. Cancer Genet Cytogenet 2000; 116: 66–73
   PubMedGoogle Scholar
• Coindre JM. Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology 2003; 43: 1–16
   PubMed Web of Science ®Google Scholar
• Fisher C. The comparative roles of electron microscopy and immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology 2006; 48: 32–41
   PubMedGoogle Scholar
• Barr FG, Chatten J, D'Cruz CM, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 1995; 273: 553–557
   PubMed Web of Science ®Google Scholar
• Bridge JA, Sandberg AA. Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skel Radiol 2000; 29: 249–258
   PubMed Web of Science ®Google Scholar
• Athale UH, Shurtleff SA, Jenkins JJ, et al. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor. J Pediatr Hematol Oncol 2001; 23: 99–104
   PubMed Web of Science ®Google Scholar
• Jambhekar NA, Bagwan IN, Ghule P, et al. Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors. Arch Pathol Lab Med 2006; 130: 1813–1818
   PubMedGoogle Scholar
• Lazar A, Abruzzo LV, Pollock RE, Lee S, Czerniak B. Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas. Arch Pathol Lab Med 2006; 130: 1199–1207
   PubMed Web of Science ®Google Scholar
• Fletcher JA. Cytogenetic analysis of soft tissue tumrors. Enzinger and Weis's Soft Tissue Tumors, ed 4, SW Weiss, JR Goldblum. Mosby, St. Louis, MO 2001; 125–146
   Google Scholar
• Unni, KK, Inward, CY, Bridge, JA, Kindblom, L-G, Wold, LE. AFIP Fascicle on Tumors of Bone. American Registry of Pathology Press, (4th series). Washington, DC 2005
   Google Scholar
• Seemayer TA, Vekemans M, de Chadarevian JP. Histological and cytogenetic findings in a malignant tumor of the chest wall and lung (Askin tumor). Virchows Arch A 1985; 408: 289–296
   Google Scholar
• Jimenez RE, Folpe AL, Lapham RL, et al. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol 2002; 26: 320–327
   PubMed Web of Science ®Google Scholar
• Reinhard H, Aliani S, Ruebe C, Stöckle M, Leuschner I, Graf N. Wilms’ tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. J Clin Oncol 2004; 22: 4500–4506
   PubMedGoogle Scholar
• Perlmutter AE, Saunders SE, Zaslau S, Chang WW, Farivar-Mohseni H. Primary synovial sarcoma of the kidney. Int J Urol 2005; 12: 760–762
   PubMedGoogle Scholar
• Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994; 25: 396–399
   PubMed Web of Science ®Google Scholar
• Stevenson A, Chatten J, Bertoni F, Miettinen M. CD99 (p30/32MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience. Appl Immunohistochem 1994; 2: 231–240
   Google Scholar
• Dei Tos AP, Wadden C, Calonje E, et al. Immunohistochemical demonstration of glycoprotein p30/32(MIC2) (CD99) in synovial sarcoma: a potential cause of diagnostic confusion. Appl Immunohistochem 1995; 3: 168–173
   Google Scholar
• Halliday BE, Slagel DD, Elsheikh TE, Silverman JF. Diagnostic utility of MIC-2 immunocytochemical staining in the differential diagnosis of small blue cell tumors. Diagn Cytopathol 1998; 19: 410–416
   PubMed Web of Science ®Google Scholar
• Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000; 24: 1657–1662
   PubMed Web of Science ®Google Scholar
• Sebire NJ, Gibson S, Rampling D, Williams S, Malone M, Ramsay AD. Immunohistochemical findings in embryonal small round cell tumors with molecular diagnostic confirmation. Appl Immunohistochem Mol Morphol 2005; 13: 1–5
   PubMedGoogle Scholar
• Llombart-Bosch A, Navarro S. Immunohistochemical detection of EWS and FLI-1 proteins in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression. Appl Immunohistochem Mol Morphol 2001; 9: 255–260
   PubMedGoogle Scholar
• Ellison DA, Parham DM, Bridge JA, Beckwith JB. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center. Hum Pathol 2006; 38: 205–211
   PubMedGoogle Scholar
• Kushner BH, LaQuaglia MP, Cheung NK, et al. Clinically critical impact of molecular genetic studies in pediatric solid tumors. Med Pediatr Oncol 1999; 33: 530–535
   PubMedGoogle Scholar
• Hostein I, Andraud-Fregeville M, Guillou L, et al. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens. Cancer 2004; 101: 2817–2824
   PubMedGoogle Scholar
• Cerveira N, Torres L, Ribeiro FR, et al. Multimodal genetic diagnosis of solid variant of alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 2005; 163: 138–143
   PubMedGoogle Scholar
• Nishio J, Althof PA, Bailey JM, et al. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest 2006; 86: 547–556
   PubMedGoogle Scholar
• Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998; 22: 673–682
   PubMed Web of Science ®Google Scholar
• Pelmus M, Guillou L, Hostein I, Sierankowski G, Lussan C, Coindre JM. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases. Am J Surg Pathol 2002; 26: 1434–1440
   PubMed Web of Science ®Google Scholar
• Bergman S, Brownlee NA, Geisinger KR, et al. Diagnostic pitfalls associated with fine-needle aspiration biopsy in a patient with the myxoid variant of monophasic fibrous synovial sarcoma. Diagn Cytopathol 2006; 34: 761–767
   PubMedGoogle Scholar
• Nishio J, Iwasaki H, Althof PA, et al. Identification of a ring chromosome with spectral karyotyping in a pleural synovial sarcoma. Cancer Genet Cytogenet 2005; 160: 174–178
   PubMedGoogle Scholar
• Mandahl N, Limon J, Mertens F, et al. Nonrandom secondary chromosome aberrations in synovial sarcoma with t(X;18). Int J Oncol 1995; 7: 495–499
   PubMedGoogle Scholar
• Skytting BT, Szymanska J, Aalto Y, et al. Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization. Cancer Genet Cytogenet 1999; 115: 39–46
   PubMedGoogle Scholar
• Aubry M-C, Bridge JA, Wickert R, Tazelaar HD. Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript. Am J Surg Pathol 2001; 25: 776–781
   PubMedGoogle Scholar
• Essary LR, Vargas SO, Fletcher CDM. Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset. Cancer 2002; 94: 459–469
   PubMed Web of Science ®Google Scholar
• Cote JF, de Saint-Maur PP, Coindre JM, Bruneval P, Badoual C. Unusual strong CD34 positivity in a thoracic monophasic fibrous synovial sarcoma. Histopathology 2004; 45: 539–540
   PubMedGoogle Scholar
• Begueret H, Galateau-Salle F, Guillou L, et al. Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group. Am J Surg Pathol 2005; 29: 339–346
   PubMed Web of Science ®Google Scholar
• Rdzanek M, Fresco R, Pass HI, Carbone M. Spindle cell tumors of the pleura: differential diagnosis. Semin Diagn Pathol 2006; 23: 44–55
   PubMed Web of Science ®Google Scholar
• Dei Tos AP, Pedeutour F. Dedifferentiated liposarcoma. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone, CDM Fletcher, KK Unni, F Mertens. IARC Press, Lyon 2002; 38–39
   Google Scholar
• SW Weiss, Goldblum, JR. Enzinger and Weis's Soft Tissue Tumors ed 4. Mosby, St. Louis, MO 2001; 641–693
   Google Scholar
• Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet 2004; 155: 1–24
   PubMedGoogle Scholar
• Meis-Kindblom JM, Sjogren H, Kindblom LG, et al. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis. Virchows Arch 2001; 439: 141–151
   PubMedGoogle Scholar
• Segura-Sanchez J, Gonzalez-Campora R, Pareja-Megia MJ, Garcia-Escudero A, Galera-Ruiz H, Lopez-Beltran A. Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma. Anticancer Res 2006; 26: 4937–4942
   PubMedGoogle Scholar
• Shimada S, Ishizawa T, Ishizawa K, Matsumura T, Hasegawa T, Hirose T. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum Pathol 2006; 37: 1123–1129
   PubMedGoogle Scholar
• Dei Tos AP. Liposarcoma: new entities and evolving concepts. Ann Diagn Pathol 2000; 4: 252–266
   PubMedGoogle Scholar
• Kanamori M, Antonescu C, Scott M, et al. Extra copies of chromosomes 7, 8, 12, 19, and 21 are recurrent in adamantinoma. J Mol Diagn 2001; 3: 16–21
   PubMedGoogle Scholar
• Betts DR, Cohen N, Leibundgut KE, et al. Characterization of karyotypic events and evolution in neuroblastoma. Pediatr Blood Cancer 2005; 44: 147–157
   PubMedGoogle Scholar
• Finkelstein SD, Hirose T, VandenBerg SR. World Health Organization Classification of Tumours: Pathology and Genetics Tumours of the Nervous System, P Kleihues, WK Cavanee. IARC Press, Lyon 2000; 149–162
   Google Scholar
• George RE, London WB, Cohn SL, et al. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 2005; 23: 6466–6473
   PubMed Web of Science ®Google Scholar
• Bridge JA, Liu J, Suijkerbuijk R, et al. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 2002; 33: 310–321
   PubMedGoogle Scholar
• Kodet R, Newton WA, Hamoudi AB, Asmar L, Jacobs DL, Maurer HM. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features: a report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 1993; 17: 443–453
   PubMed Web of Science ®Google Scholar